Clinical trial
High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell…
NCT00002567 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002567 |
|---|---|
| Title | High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission |
| Official title | PHASE II STUDY EVALUATING AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION FOR ACUTE LEUKEMIAS |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bone Marrow Ablation, Leukemia |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, etoposide, peripheral blood stem cell transplantation, low-LET electron therapy, low-LET photon therapy |
| Enrollment | 45 |
| Start date | Mar 1, 1994 |
| Primary completion | Nov 1, 2000 |
| Completion | Nov 1, 2000 |
| First posted | May 24, 2004 |
| Last update posted | Jun 27, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: